FGFR4, a protein recognized by MS for its crucial involvement in enhancing the malignant phenotype of cancer cells and affecting the tumor microenvironment, captured our attention and was pinpointed as a potential protein interacting with cLMNB1 (Fig. 4A). This evidence concerns the gene FGFR4 and neoplasm.